Brian Mueller - 15 Mar 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: EVP, Chief Financial Officer
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 15 Mar 2023
Net transactions value: -$608,718
Form type: 4
Filing time: 17 Mar 2023, 21:42:21 UTC
Previous filing: 02 Mar 2023
Next filing: 30 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Award	$0	+9,630	+18%	$0.000000	62,266	15 Mar 2023	Direct	F1
transaction	BMRN	Common Stock	Tax liability	$237,600	-2,708	-4.3%	$87.74	59,558	15 Mar 2023	Direct
transaction	BMRN	Common Stock	Tax liability	$371,118	-3,973	-6.7%	$93.41	55,585	16 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to buy Common Stock)	Award	$0	+21,970		$0.000000	21,970	15 Mar 2023	Common Stock	21,970	$87.74	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on March 15, 2023. Price not applicable.
F2	Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter.